PUBLISHER: IMARC | PRODUCT CODE: 1792341
PUBLISHER: IMARC | PRODUCT CODE: 1792341
The North America DNA sequencing products market size reached USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.2 Billion by 2033, exhibiting a growth rate (CAGR) of 12.42% during 2025-2033. The growing prevalence of various chronic diseases, rising healthcare expenditure, and increasing geriatric population represent some of the key factors driving the market.
Deoxyribonucleic acid (DNA) sequencing refers to the technique for identifying the exact sequence of nucleotides, such as A, T, C, and G, or bases, in a DNA molecule. It comprises various technologies, such as sanger sequencing, capillary electrophoresis and fragment analysis, and next-generation sequencing (NGS). It is performed on mitochondrial (mtDNA) polymerase chain reaction (PCR) products by using fluorescence-based chemistry. It is essential in determining the function of genes and other parts of the human genome. It assists in understanding various diseases and treatments related to it. It is utilized for biomarkers, diagnostics, reproductive health, forensics, and personalized medicines. As it is widely employed in academic and government research institutes, pharmaceutical and biotechnology companies, hospitals, and clinics, the demand for DNA sequencing products is increasing in North America.
At present, the rising demand for DNA sequencing products due to the increasing investment in new drug discoveries and developments represents one of the primary factors supporting the growth of the market in North America. Besides this, the growing demand for DNA sequencing products due to the growing prevalence of various chronic diseases, such as cancer, arthritis, asthma, diabetes, chronic obstructive pulmonary disease (COPD), and heart attack among individuals, is offering a positive market outlook in the region. Additionally, governing agencies of North America are implementing favorable policies to encourage the adoption of DNA sequencing products. This, coupled with the rising healthcare expenditure by various public and private companies, is propelling the growth of the market. Apart from this, technological advancements in DNA sequencing products and equipment is offering lucrative growth opportunities to industry investors across the region. Moreover, the increasing demand for DNA sequencing products to detect various diseases among individuals, along with the rising geriatric population, is bolstering the growth of the market in North America. In addition, the presence of prominent drug manufacturers and skilled professionals in the healthcare sector is positively influencing the market. Furthermore, key players are introducing third generation sequencing and single-molecule real-time sequencing (SMRT), which is an effective technique provided to use cost-effective chemicals, which is projected to strengthen the growth of the market in North America.